Jeeva Educational Trust

Brickwork Ratings reaffirms the ratings for the Bank Loan Facilities of Rs. 108.83 Crs.of Jeeva Educational Trust

Particulars

Facilities**	Amount (Rs.Crs.)		Tenure	Rating#
Facilities**	Previous	Present	Tenure	Previous (10 May 2022)	Present
Fund Based	95.64	98.12	Long Term	BWR BB+/Stable Upgrade	BWR BB + /Stable Reaffirmation
Non Fund Based	10.21	10.71	Short Term	BWR A4+ reaffirmation	BWR A4 + Reaffirmation
Grand Total	105.85	108.83	(Rupees One Hundred Eight Crores and Eighty Three lakhs Only)

#Please refer to BWR website www.brickworkratings.com for definition of the ratings
**Details of Bank Loan facilities,consolidation or instruments are provided in Annexure

RATING ACTION / OUTLOOK

Brickwork Ratings reaffirms the ratings for the enhanced bank facilities of Jeeva Educational Trust at BWR BB+/A4+(stable).

KEY RATING DRIVERS

Credit Strengths:

Completion of Phase 1 :
JET has built AMCH consisting of 330 beds, 60 ICU beds and a medical college of 150 seats in phase 1 within the budgeted cost and time. The hospital specializes in various disciplines like General Medicine, Pediatrics, Pulmonary Medicine, Dermatology, Psychiatry, General surgery, Orthopedics, ENT, Dentistry, Ophthalmology, and OBG etc. The enrollment for the first batch of MBBS students has been 100% and 90% of the course fees has been received by 31st March 2022.
Diversified source of revenue :
- The Trust has diversified sources of revenues from the hospital and various educational institutes.
  - AMCH: Revenues from MBBS course and hospital services. The Hospital has been granted covid care hospital status since the second wave of pandemic. The fees per student for the MBBS course is Rs 12 lakhs per student for FY22 and the current enrollment status is 100%.
  - Arunai College of Pharmacy: The enrollment ratio for the course is 99% and the fees for B PHARM course is 1 lakh/student and for D PHARM course is 80000/student for FY22. Current year enrollment in both these faculties has been 100%. The course is for four years and started in 2019.
  - Arunai Institute of Nursing Education and Research: The enrollment ratio for the course is 95%. While the initial enrollment sanction for BSC Nursing was 40 seats, sanctioned intake has now increased to 100 students (Total seats 240 of which 210 filled). The fees for this four-year course which was started in 2011 is 1,00,000/student for FY22.
Strong Trustee background :

The founder and Chairman, Mr. E. V. Velu has experience of around three decades in the education sector. Hence, experience of the promoters and their understanding of the dynamics of the industry are expected to support the business risk profile.

Credit Risks:

Moderate scale of operations :

The scale of operations is modest as marked by total operating revenues of Rs. 5.16 crs and negative PAT of Rs. -1.06 crs, in FY 21. However, post phase one of the pandemic the trust has done well with revenues from hospital and education institutes contributing to Rs. 39.15 Crs of Total Operating income and PAT of Rs. 6.43 Crs during FY22E (Management Certified financials). The total debt (TD) as at March 2022 was Rs. 123 Crs. and Tangible Networth (TNW) was at 35.36 Crs. translating to TD/TNW of 3.5x. The TD/TNW, though expected to moderate from FY22E levels, is likely to remain ~2x in FY23 as the trust would be initiating phase 2 expansion plan.
Project execution, time and cost overrun risk :

The Trust is in process of enhancing the Hospital bed capacity by 650 beds with an estimated project cost of Rs. 130 Crs. The project would be funded in the ratio of 70-75% debt and 25-30% equity which will impact the gearing and debt coverage metrics. Moreover there is a risk of time and cost overrun keeping in view the current pandemic situation. The risk is mitigated to a certain extent by successful completion of phase 1 of the expansion by the trust post the lockdown restrictions were lifted. The trust is planning to start a Postgraduate course for MBBS students once the expansion is completed which is likely to be December 2023.
Exposure to regulatory and reputation risk :

The healthcare and educational sector is highly regulated by the government and exposed to unfavorable changes in government policies from time to time. Any restrictions on pricing levied by central and/or state government organizations could constrain the profitability margins going forward. Reputation risk is an inherent risk in the Healthcare Industry, and any act of negligence by the Hospital staff may tarnish the image of the Hospital.

ANALYTICAL APPROACH - Standalone

For arriving at its ratings, BWR has considered JET’s audited financial for the year FY21, Management certified financials for the year FY22, Projections and the other information as shared by the trust and available in public domain and applied its rating methodology as detailed in the Rating Criteria detailed below (hyperlinks provided at the end of this rationale).

RATING SENSITIVITIES

Positive Sensitivities

Sustained growth in scale along with improvement in profit margins, prudent working capital management, strengthening of liquidity and financial risk profile.

Negative Sensitivities

Delay in project execution with significant time and / or cost overruns.
Unanticipated delay in receipts leading to cash flow mismatches, decline in enrollment ratio or lower occupancy, weakening the operating performance and profitability.

LIQUIDITY INDICATORS - Adequate

In order to meet its working capital requirements, the organization has availed OD facility from Indian Bank and the average utilization of cash credit limits is about 13.41% in the last six months ending August 2022. ISCR and DSCR as per management certified FY22 numbers are 2.97x(since there is a moratorium on long-term debt till FY23) Cash and Cash Equivalent stood at Rs. 7.2 Crs at 31st March 2022. The Trust is likely to generate NCA of Rs. 14.17 Crs. and 31.65 Crs. which should be sufficient to meet debt repayment obligation of Rs. 2.25 Crs. and Rs. 8 Crs in FY23 & FY24 respectively.

ABOUT THE ENTITY

JET is a registered charitable trust established dated 3Nov1998. The registered office of the trust is at Chennai, Tamil Nadu. JET is a part of Arunai Group of Institutions. Mr. E. V. Velu, Mr. E. V. Kumaran and Mrs. Vijitha Kumaran are the trustees of the JET. Arunai Group of Institutions has Educational Institutions which are managed by SAET & JET, Tamil Nadu . These trusts are dedicated to education, healthcare and community service. It is based out of Tiruvannamalai. Arunai Group of Institutions was established in 1991 with the purpose of augmenting rural education, healthcare and community service which was started by Mr. E. V. Velu of Arunai Group of Institution and his family members Mrs. Sankari Velu , Mr. E. V. Kumaran & Mrs. Vijitha Kumaran. Having achieved the successful establishment of the 10 Institutions, the management planned to establish a Medical College & Hospital under the name “Arunai Medical College & Hospital” at Tiruvannamalai proposed to be executed in two phases.

Total project cost for phase-I is Rs 135 Crs out of which Rs 90.00 Crs was funded by way of a term loan and the rest from promoter’s contribution of Rs. 45 Crs . The total cost of phase 2 is 130 Crs. to be funded in the ratio of 70-75% debt (yet to be tied up) and 25-30% equity. Phase 2 is likely to be operational by December 2023. Phase 2 consists of adding 650 additional beds to the current capacity of 330 beds and also starting PG courses for MBBS students.

KEY FINANCIAL INDICATORS (Standalone)

Key Parameters	Units	FY 20-21 (Audited)	FY 19-20 (Audited)
Operating Revenue	Rs.Crs.	5.16	4.72
EBITDA	Rs.Crs.	-0.39	1.32
PAT	Rs.Crs.	-1.06	0.54
Corpus	Rs.Crs.	28.93	13.91
Total Debt/Corpus	Times	1.42	0.07
Current Ratio	Times	0.86	0.93

STATUS OF NON-COOPERATION WITH PREVIOUS CRA

RATING HISTORY FOR THE PREVIOUS THREE YEARS (including withdrawal and suspended)

Facilities	Current Rating (2022)			2022 (History)		2021		2020		2019
Type	Tenure	Amount (Rs.Crs.)	Rating	Date	Rating	Date	Rating	Date	Rating	Date	Rating
Fund Based	LT	98.12	BWR BB+/Stable (Reaffirmation)	10May2022	BWR BB+Stable (Upgrade)	04Feb2022	BWR BB Stable (Assignment)	NA	NA	NA	NA
Non Fund Based	ST	10.71	BWR A4+ (Reaffirmation)	10May2022	BWR A4+ (reaffirmation)	04Feb2022	BWR A4+ (Assignment)	NA	NA	NA	NA
Grand Total		108.83	(Rupees One Hundred Eight Crores and Eighty Three lakhs Only)

COMPLEXITY LEVELS OF THE INSTRUMENTS - Simple

BWR complexity levels are meant for educating investors. The BWR complexity levels are available at www.brickworkratings.com / download / ComplexityLevels.pdf. Investors queries can be sent to info@brickworkratings.com.

Hyperlink/Reference to applicable Criteria

Analytical Contacts
Prashant Sahadev Mondkar Ratings Analyst Board : +91 22 2831 1426, +91 22 2831 1439 prashant.sm@brickworkratings.com	Chintan Dilip Lakhani Director- Ratings chintan.l@brickworkratings.com
1-860-425-2742 \| media@brickworkratings.com

Jeeva Educational Trust

ANNEXURE-I

Details of Bank Facilities rated by BWR

SL.No.	Name of the Bank/Lender	Type Of Facilities	Long Term(Rs.Crs.)	Short Term(Rs.Crs.)	Total(Rs.Crs.)
1	Indian Bank	Term Loan - Sanctioned	59.89	_	59.89
2	Indian Bank	Term Loan - Sanctioned	26.75	_	26.75
3	Indian Bank	Term Loan	2.48	_	2.48
4	Indian Bank	Over Draft - Sanctioned	9.00	_	9.00
5	Indian Bank	Bank Guarantee - Sanctioned	_	10.71	10.71
Total			98.12	10.71	108.83
TOTAL (Rupees One Hundred Eight Crores and Eighty Three lakhs Only)

Print and Digital Media

The Rating Rationale is sent to you for the sole purpose of dissemination through your print, digital or electronic media. While it may be used by you acknowledging credit to BWR, please do not change the wordings in the rationale to avoid conveying a meaning different from what was intended by BWR. BWR alone has the sole right of sharing (both direct and indirect) its rationales for consideration or otherwise through any print or electronic or digital media.

About Brickwork Ratings

Brickwork Ratings (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by Reserve Bank of India [RBI], offers credit ratings of Bank Loan, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. BWR has rated over 12,000 medium and large corporates and financial institutions’ instruments. BWR has also rated NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations. BWR has Canara Bank, a leading public sector bank, as one of the promoters and strategic partner. BWR has its corporate office in Bengaluru and a country-wide presence with its offices in Ahmedabad, Chandigarh, Chennai, Hyderabad, Kolkata, Mumbai and New Delhi along with representatives in 150+ locations.

Disclaimer

Brickwork Ratings India Pvt. Ltd. (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by the Reserve Bank of India [RBI], offers credit ratings of Bank Loan facilities, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. [ hereafter referred to as "Instruments"]. BWR also rates NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations.

BWR wishes to inform all persons who may come across Rating Rationales and Rating Reports provided by BWR that the ratings assigned by BWR are based on information obtained from the issuer of the instrument and other reliable sources, which in BWR's best judgment are considered reliable. The Rating Rationale / Rating Report & other rating communications are intended for the jurisdiction of India only. The reports should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in Europe and also the USA).

BWR also wishes to inform that access or use of the said documents does not create a client relationship between the user and BWR.

The ratings assigned by BWR are only an expression of BWR's opinion on the entity / instrument and should not in any manner be construed as being a recommendation to either, purchase, hold or sell the instrument.

BWR also wishes to abundantly clarify that these ratings are not to be considered as an investment advice in any jurisdiction nor are they to be used as a basis for or as an alternative to independent financial advice and judgment obtained from the user's financial advisors. BWR shall not be liable to any losses incurred by the users of these Rating Rationales, Rating Reports or its contents. BWR reserves the right to vary, modify, suspend or withdraw the ratings at any time without assigning reasons for the same.

BWR's ratings reflect BWR's opinion on the day the ratings are published and are not reflective of factual circumstances that may have arisen on a later date. BWR is not obliged to update its opinion based on any public notification, in any form or format although BWR may disseminate its opinion and analysis when deemed fit.

Neither BWR nor its affiliates, third party providers, as well as the directors, officers, shareholders, employees or agents (collectively, "BWR Party") guarantee the accuracy, completeness or adequacy of the Ratings, and no BWR Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Rating Rationales or Rating Reports. Each BWR Party disclaims all express or implied warranties, including, but not limited to, any warranties of merchantability, suitability or fitness for a particular purpose or use. In no event shall any BWR Party be liable to any one for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Rating Rationales and/or Rating Reports even if advised of the possibility of such damages. However, BWR or its associates may have other commercial transactions with the company/entity. BWR and its affiliates do not act as a fiduciary.

BWR keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of BWR may have information that is not available to other BWR business units. BWR has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

BWR clarifies that it may have been paid a fee by the issuers or underwriters of the instruments, facilities, securities etc., or from obligors. BWR's public ratings and analysis are made available on its web site, www.brickworkratings.com. More detailed information may be provided for a fee. BWR's rating criteria are also generally made available without charge on BWR's website.

This disclaimer forms an integral part of the Ratings Rationales / Rating Reports or other press releases, advisories, communications issued by BWR and circulation of the ratings without this disclaimer is prohibited.

BWR is bound by the Code of Conduct for Credit Rating Agencies issued by the Securities and Exchange Board of India and is governed by the applicable regulations issued by the Securities and Exchange Board of India as amended from time to time.